These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

941 related articles for article (PubMed ID: 18093111)

  • 21. Treatment of recurrent perforating intestinal ulcers with thalidomide in Behçet's disease.
    Sayarlioglu M; Kotan MC; Topcu N; Bayram I; Arslanturk H; Gul A
    Ann Pharmacother; 2004 May; 38(5):808-11. PubMed ID: 15010523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases.
    Epstein JB; Gorsky M; Epstein MS; Nantel S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jan; 91(1):56-61. PubMed ID: 11174572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silver nitrate cautery in aphthous stomatitis: a randomized controlled trial.
    Alidaee MR; Taheri A; Mansoori P; Ghodsi SZ
    Br J Dermatol; 2005 Sep; 153(3):521-5. PubMed ID: 16120136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyaluronic acid versus dexamethasone for the treatment of recurrent aphthous stomatitis in children: efficacy and safety analysis.
    Yang Z; Li M; Xiao L; Yi Z; Zhao M; Ma S
    Braz J Med Biol Res; 2020; 53(8):e9886. PubMed ID: 32609262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary epidermal growth factor levels in Behçet's disease and recurrent aphthous stomatitis.
    Adişen E; Aral A; Aybay C; Gürer MA
    Dermatology; 2008; 217(3):235-40. PubMed ID: 18663306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical assessment of the effect of a matrix metalloproteinase inhibitor on aphthous ulcers.
    Skulason S; Holbrook WP; Kristmundsdottir T
    Acta Odontol Scand; 2009; 67(1):25-9. PubMed ID: 18991147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of topical hyaluronic acid in the management of oral lichen planus.
    Nolan A; Badminton J; Maguire J; Seymour RA
    J Oral Pathol Med; 2009 Mar; 38(3):299-303. PubMed ID: 19267842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The close association between dental and periodontal treatments and oral ulcer course in behcet's disease: a prospective clinical study.
    Karacayli U; Mumcu G; Simsek I; Pay S; Kose O; Erdem H; Direskeneli H; Gunaydin Y; Dinc A
    J Oral Pathol Med; 2009 May; 38(5):410-5. PubMed ID: 19320802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The therapeutic and prophylactic role of oral zinc sulfate in management of recurrent aphthous stomatitis (ras) in comparison with dapsone.
    Sharquie KE; Najim RA; Al-Hayani RK; Al-Nuaimy AA; Maroof DM
    Saudi Med J; 2008 May; 29(5):734-8. PubMed ID: 18454224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.
    Melikoglu M; Fresko I; Mat C; Ozyazgan Y; Gogus F; Yurdakul S; Hamuryudan V; Yazici H
    J Rheumatol; 2005 Jan; 32(1):98-105. PubMed ID: 15630733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of aphthosis with thalidomide and with colchicine].
    Genvo MF; Faure M; Thivolet J
    Dermatologica; 1984; 168(4):182-8. PubMed ID: 6724071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Behcet's disease and recurrent aphthous ulcer according to characteristics of gastrointestinal symptoms.
    Rhee SH; Kim YB; Lee ES
    J Korean Med Sci; 2005 Dec; 20(6):971-6. PubMed ID: 16361807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide.
    Letsinger JA; McCarty MA; Jorizzo JL
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):500-8. PubMed ID: 15761429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. General manifestations of Behçet's syndrome and the success of CO2-laser as treatment for oral lesions: a review of the literature and case presentation.
    Demetriades N; Hanford H; Laskarides C
    J Mass Dent Soc; 2009; 58(3):24-7. PubMed ID: 19927952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subantimicrobial dose doxycycline in the treatment of recurrent oral aphthous ulceration: a pilot study.
    Preshaw PM; Grainger P; Bradshaw MH; Mohammad AR; Powala CV; Nolan A
    J Oral Pathol Med; 2007 Apr; 36(4):236-40. PubMed ID: 17391302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical minocycline for managing symptoms of recurrent aphthous stomatitis.
    Gorsky M; Epstein J; Raviv A; Yaniv R; Truelove E
    Spec Care Dentist; 2008; 28(1):27-31. PubMed ID: 18271771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The spectrum of mucocutaneous manifestations in Adamantiades-Behçet's disease in Greece.
    Vaiopoulos G; Konstantopoulou P; Evangelatos N; Kaklamanis PH
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):434-8. PubMed ID: 19758264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind trial of depot corticosteroids in Behçet's syndrome.
    Mat C; Yurdakul S; Uysal S; Gogus F; Ozyazgan Y; Uysal O; Fresko I; Yazici H
    Rheumatology (Oxford); 2006 Mar; 45(3):348-52. PubMed ID: 16263779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical pathological analysis of recurrent oral ulcer and Behçet's syndrome].
    Gao C
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1990 Mar; 25(2):82-5, 125. PubMed ID: 2119997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of aphthous ulceration with topical quercetin: a randomized clinical trial.
    Hamdy AA; Ibrahem MA
    J Contemp Dent Pract; 2010 Jul; 11(4):E009-16. PubMed ID: 20953559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.